Cite
HARVARD Citation
Chang, Y. et al. (n.d.). Evaluation of Hepatic Impairment Dosing Recommendations in FDA‐Approved Product Labels. Journal of clinical pharmacology. pp. 962-966. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chang, Y. et al. (n.d.). Evaluation of Hepatic Impairment Dosing Recommendations in FDA‐Approved Product Labels. Journal of clinical pharmacology. pp. 962-966. [Online].